CD8A and infection: In keeping with the cellular dogma of TB vaccine design, it is m-EsxI, which induces the greatest CD8+ T cell response of any single antigen vaccine and a strong CD4+ T cell response, that is the only single construct to achieve statistically significant protection against in vivo Mtb infection, albeit in only one of the two relevant infection studies.